Dr. Ken Friedman, author of the book
The New Silver Solution, states, Silver Biotics
may be used every day to support a healthy immune
system against harmful and resistant bacteria.
e
Patented Manufacturing Process
e
Immune
Defense
Against
Harmful
and
Resistant
Bacteria
e
Doctor
Recommended
as
a
Natural
Alternative
e
Proven Effective in Human Studies
e
Scientifically
Supported
e Tested
and
Developed
by
Scientists,
Major
Universities,
Certified
Independent
Laboratories
and International Health Consortiums.
e
Proven to Inhibit and Kill Yeast
e
Completely Safe/Non Toxic
e
96.8% Bioavailability
Silver Biotics
MineralSupplement
Silver Biotics is the national marketing label
for the product also known as the ASAP Solutionฎ (GSA
# GS-07F-0826N). The
product is currently only sold as a mineral
supplement. The
product is currently sold in health food stores across
the United States,
Canada,
Russia
and numerous other countries. It
is currently used by hundreds-of-thousands of people
worldwide, under a number of different brand labels,
as a daily use supplement. In
general, the product is used to boost the immune
system and to help fight off disease and infection. There have been no reported
contra indications with its continued use, with
estimated sales of over a million bottles. Daily intake usage of the
Silver Biotics product meets the daily
intake safety standards as established by the U.S. EPA for
silver consumption (EPA RED Document, page 2, 2nd
paragraph, 1991). The
product has already been approved by the country of
Ghana West Africa as an alternative to antibiotics,
based on their own human studies.
Malaria
Treatment
Silver Biotics is an anti-microbial mineral
supplement that has been and is being tested worldwide
in oral human studies, against a number of pathogens and
diseases which are deadly to humans.
Of special interest are the three completed human
studies from Africa,
in which the product was used as an oral intake
treatment against Malaria. In
the studies, at a dosage of just two teaspoons used
three times daily, 100% of the test patients were able
to obtain full recovery from Malaria in an average of just
five days, with the shortest cases taking
three-and-a-half days and the longest cases taking only
10 days. Testing after
treatment showed that the Malaria protozoa were no
longer present in the blood. Additional
human study Malaria tests are currently underway. The new test results should be
available in the next 60-90 days. Copies of the three
completed Malaria test summaries are available upon
request.
The Hospitals
The first series of 58 trials was accomplished at three
(3) hospitals in Ghana, West Africa. The three hospitals
were: the Air Force Station Hospital under the direction
of Dr. Kwabiah, The Kone-Bu Teaching Hospital under the
direction of Dr. Sackey, and the Justab Clinic/Maternity
under the direction of Dr. Abraham.
Diversity Of Use
Silver
Biotics~ was tried on a wide diversity of human
problems, including malaria, upper respiratory tract
infections, urinary tract infections, sinusitis
infections, vaginal yeast infections, eye, nose and ear
infections, cuts and fungal skin infections and even for
sexually transmitted diseases like gonorrhea etc. Silver
BioticsTM was used as both an internal and external
antibiotic alternative.
The Product
All treatments were performed using the American Biotech
Labs Silver BioticsTM at a strength of 10 parts per
million.
he diagram below details the
study performed by BYU.
Ailment
Pathogen
Silver
Biotics
|
Boils
|
Staphylococcus aureus
|
Killed @ 5 ppm
|
|
Bone
Inflammation (Osteomyelitis)
|
Staphylococcus
aureus
|
Killed @ 5
ppm
|
|
Bowel
Infection (Bacillary Dysentery)
|
Shigella
boydii
|
Killed @
2.5 ppm
|
|
Burn
Infections
|
Pseudomonas
aeruginosa
|
Killed @ 5
ppm
|
|
Dental
Plaque
|
Streptococcus
mutans
|
Killed @ 5
ppm
|
|
Diarrhea
(bloody)
|
Shigella
boydii
|
Killed @
2.5 ppm
|
|
Diarrhea
|
E. Coli
|
Killed @
2.5 ppm
|
|
Ear
Infection
|
Haemophilus
influenzae
|
Killed @
1.25 ppm
|
|
Ear
Infection
|
Streptococcus
pneumonie
|
Killed @
2.5 ppm
|
|
Enteric
Fever
|
Salmonella
typhimurium
|
Killed @
2.5 ppm
|
|
Epiglottitis
(in children)
|
Haemophilus
influenzae
|
Killed @
1.25 ppm
|
|
Eye
Infections
|
Staphylococcus
aureus
|
Killed @ 5
ppm
|
|
Eye
Infections (Corneal Ulcers-Keratitis)
|
Pseudomonas
aeruginosa
|
Killed @ 5
ppm
|
|
Food
Poisoning
|
Salmonella
Arizona
|
Killed @ 5
ppm
|
|
Food
Poisoning
|
Salmonella
typhimurium
|
Killed @
2.5 ppm
|
|
Food
Poisoning
|
E. Coli
|
Killed @
2.5 ppm
|
|
Heart Valve
Infection (Endocarditis)
|
Streptococcus
faecalis
|
Killed @
2.5 ppm
|
|
Heart Valve
Infection (Endocarditis)
|
Streptococcus
gordonii
|
Killed @ 5
ppm
|
|
Meningitis
|
Haemophilus
influenzae
|
Killed @
1.25 ppm
|
|
Meningitis
|
Enterobacter
aerogenes
|
Killed @
2.5 ppm
|
|
Meningitis
|
Pseudomonas
aeruginosa
|
Killed @ 5
ppm
|
|
Meningitis
|
Streptococcus
pneumonie
|
Killed @
2.5 ppm
|
|
Nosocomial
Infections (from hospitals)
|
Klebsiella
pneumoniae
|
Killed @
2.5 ppm
|
|
Nosocomial
Infections (from hospitals)
|
Pseudomonas
aeruginosa
|
Killed @ 5
ppm
|
|
Nosocomial
Infections (from hospitals)
|
Streptococcus
pyogenes
|
Killed @
1.25 ppm
|
|
Pneumonia
|
Staphylococcus
aureus
|
Killed @ 5
ppm
|
|
Pneumonia
|
Haemophilus
influenzae
|
Killed @
1.25 ppm
|
|
Pneumonia
|
Pseudomonas
aeruginosa
|
Killed @ 5
ppm
|
|
Pneumonia
|
Streptococcus
pneumonie
|
Killed @
2.5 ppm
|
|
Respiratory
Infections (Upper)
|
Streptococcus
pyogenes
|
Killed @
1.25 ppm
|
|
Respiratory
Tract Infections
|
E. Coli
|
Killed @
2.5 ppm
|
|
Respiratory
Tract Infections (lower)
|
Klebsiella
pneumoniae
|
Killed @
2.5 ppm
|
|
Scarlet
Fever
|
Streptococcus
pyogenes
|
Killed @
1.25 ppm
|
|
Septicemia
|
Enterobacter
aerogenes
|
Killed @
2.5 ppm
|
|
Sinus
Infections
|
Haemophilus
influenzae
|
Killed @
1.25 ppm
|
|
Sinusitis
|
Streptococcus
pneumonie
|
Killed @
2.5 ppm
|
|
Skin
Infection (Impetigo)
|
Staphylococcus
aureus
|
Killed @ 5
ppm
|
|
Skin
Infections
|
Staphylococcus
aureus
|
Killed @ 5
ppm
|
|
Skin
Infections
|
Streptococcus
pyogenes
|
Killed @
1.25 ppm
|
|
Strep
Throat
|
Streptococcus
pyogenes
|
Killed @
1.25 ppm
|
|
Supportive
Arthritis (in children)
|
Haemophilus
influenzae
|
Killed @
1.25 ppm
|
|
Throat
Infections
|
Haemophilus
influenzae
|
Killed @
1.25 ppm
|
|
Tooth Decay
|
Streptococcus
mutans
|
Killed @ 5
ppm
|
|
Tooth Decay
|
Streptococcus
gordonii
|
Killed @ 5
ppm
|
|
Urethritis
(men)
|
Trichomoniasis
vaginalis
|
Killed @ 10
ppm
|
|
Urinary
Tract Infections
|
E. Coli
|
Killed @
2.5 ppm
|
|
Urinary
Tract Infections
|
Klebsiella
pneumoniae
|
Killed @
2.5 ppm
|
|
Urinary
Tract Infections
|
Pseudomonas
aeruginosa
|
Killed @ 5
ppm
|
|
Urinary
Tract Infections
|
Streptococcus
faecalis
|
Killed @
2.5 ppm
|
|
Urinary
Tract Infections
|
Enterobacter
aerogenes
|
Killed @
2.5 ppm
|
|
Vaginitis
(women)
|
Trichomoniasis
vaginalis
|
Killed @ 10
ppm
|
|
Wound
Infections
|
E. Coli
|
Killed @
2.5 ppm
|
|
Wound
Infections
|
Enterobacter
aerogenes
|
Killed @
2.5 ppm
|
|
Wound
Infections
|
Klebsiella
pneumoniae
|
Killed @
2.5 ppm
|
|
Wound
Infections
|
Pseudomonas
aeruginosa
|
Killed @ 5
ppm
|
|
Wound
Infections
|
Streptococcus
faecalis
|
Killed @
2.5 ppm
|
|
Yeast
Infections
|
Candida
albicans
|
Killed @ 10
ppm
|
David
A.
Revelli
Dr. Ron W. Leavitt, Ph.D.
Microbiologist
Professor of Microbiology/Molecular Biology
|
....
.
|
